Literature DB >> 16699738

Breast cancer and bone mass in older women: is bone density prescreening for mammography useful?

D Kritz-Silverstein1, D L Schneider, J Sandwell.   

Abstract

INTRODUCTION: The utility of screening mammography for older women with low bone mineral density (BMD) is controversial. This case-control study compares BMD at multiple sites in women with and without breast cancer to determine if BMD prescreening is useful in selecting women for continued screening mammograms.
METHODS: Women diagnosed with breast cancer in the preceding 4 months and age-matched controls (+/-2 years) with a normal mammogram, all aged 65 years and older, were recruited on a 1:2 basis; 237 women participated: 79 women (cases) with breast cancer and 158 controls. BMD at the lumbar spine, hip, radius, and whole body was measured with dual x-ray absorptiometry (DXA).
RESULTS: Among women with breast cancer, 17.1% had stage 0, 41.5% stage I, 40.0% stage II, and 1.4% stage III. Women with breast cancer had larger waist circumferences (p=0.002) and waist-hip ratios (p=0.01), and they exercised less (p=0.002) than women of the control group. However, there were no differences between the cases and controls for age, obesity, and reproductive and menopausal history variables, or other covariates (p>0.10). There were no differences in lumbar spine, total hip, femoral neck, midshaft radius, or total body BMD (p>0.10), although the cases had higher BMD at the ultradistal radius than the controls (means: 0.527 vs. 0.516, respectively; p=0.014). There were no differences in breast cancer risk by tertile of BMD or osteoporosis status at the hip or spine.
CONCLUSION: There is little difference in BMD between women with and without breast cancer. BMD is not useful as a prescreening predicator of mammography in older women and using it as such would result in cases of breast cancer being missed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699738     DOI: 10.1007/s00198-006-0124-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  24 in total

1.  Hip fractures in women with breast cancer.

Authors:  H O Adami; M Zack; U Kressner; I Persson; A Berglund; T Naessén; L Bergkvist
Journal:  Am J Epidemiol       Date:  1990-11       Impact factor: 4.897

2.  Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.

Authors:  K Kerlikowske; P Salzmann; K A Phillips; J A Cauley; S R Cummings
Journal:  JAMA       Date:  1999-12-08       Impact factor: 56.272

Review 3.  Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.

Authors:  G A Colditz
Journal:  J Natl Cancer Inst       Date:  1998-06-03       Impact factor: 13.506

4.  Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density.

Authors:  H S Glauber; W M Vollmer; M C Nevitt; K E Ensrud; E S Orwoll
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

Review 5.  Skeletal effects of estrogen.

Authors:  R T Turner; B L Riggs; T C Spelsberg
Journal:  Endocr Rev       Date:  1994-06       Impact factor: 19.871

6.  Fracture history and risk of breast and endometrial cancer.

Authors:  P A Newcomb; A Trentham-Dietz; K M Egan; L Titus-Ernstoff; J A Baron; B E Storer; W C Willett; M J Stampfer
Journal:  Am J Epidemiol       Date:  2001-06-01       Impact factor: 4.897

7.  Bone mineral density and the risk of breast cancer: the Rotterdam Study.

Authors:  Marjolein van der Klift; Chris E D H de Laet; Jan Willem W Coebergh; Albert Hofman; Huibert A P Pols
Journal:  Bone       Date:  2003-03       Impact factor: 4.398

8.  A prospective study of endogenous estrogens and breast cancer in postmenopausal women.

Authors:  P G Toniolo; M Levitz; A Zeleniuch-Jacquotte; S Banerjee; K L Koenig; R E Shore; P Strax; B S Pasternack
Journal:  J Natl Cancer Inst       Date:  1995-02-01       Impact factor: 13.506

9.  Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden).

Authors:  I Persson; H O Adami; J K McLaughlin; T Naessén; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

10.  Serum sex hormone levels are related to breast cancer risk in postmenopausal women.

Authors:  J F Dorgan; C Longcope; H E Stephenson; R T Falk; R Miller; C Franz; L Kahle; W S Campbell; J A Tangrea; A Schatzkin
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

View more
  4 in total

1.  Does adjuvant chemotherapy change bone mineral density and related serum biomarkers in women with breast cancer?

Authors:  Reza Safaei-Nodehi; Javad Esmaili; Ramazanali Sharifian; Shafieh Movaseghi; Sayeh Parkhideh
Journal:  Caspian J Intern Med       Date:  2017

2.  Bone mineral density in women newly diagnosed with breast cancer: a prospective cohort study.

Authors:  Merav Fraenkel; Victor Novack; Yuval Mizrakli; Michael Koretz; Ethel Siris; Larry Norton; Tali Shafat; David B Geffen
Journal:  NPJ Breast Cancer       Date:  2022-02-17

3.  Association between bone mineral density and incidence of breast cancer.

Authors:  Merav Fraenkel; Victor Novack; Yair Liel; Michael Koretz; Ethel Siris; Larry Norton; Tali Shafat; Shraga Shany; David B Geffen
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

4.  Bone mineral density and breast cancer risk: Results from the Vorarlberg Health Monitoring & Prevention Program and meta-analysis.

Authors:  G Nagel; R S Peter; E Klotz; W Brozek; H Concin
Journal:  Bone Rep       Date:  2017-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.